SAN DIEGO–(BUSINESS WIRE)–June 30, 2022–
DexCom, Inc. (NASDAQ:DXCM) today announced that it expects to release its second quarter 2022 financial results after market close on Thursday, July 28, 2022. Management will hold a conference call to review the performance of the company in the second quarter of 2022 beginning at 4:30 a.m. (Eastern time) the same day. The conference call will be webcast simultaneously. The link to the webcast will be available on Dexcom’s Investor Relations website at investor.dexcom.com and will be archived there for future reference.
To listen to the conference call, please dial (866) 374-5140 (US/Canada) or (404) 400-0571 (International) and use the confirmation number “24372094#” approximately five minutes before the time. of start.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative Continuous Glucose Monitoring (CGM) systems. Based in San Diego, Calif., Dexcom has established itself as a leader in diabetes care technology. By listening to the needs of users, caregivers and providers, Dexcom simplifies and improves diabetes management worldwide.
See the source version on businesswire.com: https://www.businesswire.com/news/home/20220630005668/en/
CONTACT: DexCom, Inc.:
Sean Christensen
Senior Director – Investor Relations and Corporate Financial Planning and Analysis
(858) 200-0200
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: DIABETES GENERAL HEALTH HEALTH MEDICAL DEVICES
SOURCE: DexCom, Inc.
Copyright BusinessWire 2022.
PUBLISHED: 06/30/2022 16:04 / DISK: 06/30/2022 16:04
http://www.businesswire.com/news/home/20220630005668/en
